Provided by Tiger Trade Technology Pte. Ltd.

Avidity Biosciences, Inc.

72.80
0.0000
Volume:- -
Turnover:- -
Market Cap:11.27B
PE:-14.64
High:72.80
Open:72.80
Low:72.80
Close:72.80
52wk High:73.06
52wk Low:21.51
Shares:154.74M
Float Shares:132.00M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.9715
EPS(LYR):-4.9715
ROE:-43.98%
ROA:-26.47%
PB:6.67
PE(LYR):-14.64

Loading ...

Avidity Biosciences Inc. Announces Date for Special Stockholders Meeting

Reuters
·
Nov 25, 2025

Sarepta provides update on SRP-1003 study

TIPRANKS
·
Nov 24, 2025

CSPC PHARMA (01093): Dual-Chain Small Interfering RNA Drug (SYH2061 Injection) Receives US Clinical Trial Approval

Stock News
·
Nov 24, 2025

HK Stock Movement | MIRXES-B (02629) Rises Nearly 8% in Early Trading, Partners with Walvax to Expand ASEAN Market and Build RNA Precision Medicine Innovation System

Stock News
·
Nov 24, 2025

HK Stock Movement | MIRXES-B (02629) Rises Over 5% in Afternoon Trading on Partnership with Walvax to Build RNA-Centric Precision Medicine Platform

Stock News
·
Nov 21, 2025

Biotech Reawakens: Policy Clarity, Breakthrough Data and a Surge in M&A

LiveWire
·
Nov 21, 2025

These 15 stocks are still showing momentum - and a market-beating edge

Dow Jones
·
Nov 21, 2025

Novartis Projects Faster Growth Through 2030 After Raising Drug Forecasts

Benzinga
·
Nov 21, 2025

Novartis Expects Key Drugs, Recent Deals to Buoy Sales Into 2030s -- Update

Dow Jones
·
Nov 20, 2025

Novartis sees sales boost from key cancer drugs

Reuters
·
Nov 20, 2025

Novartis Forecasts 2025-2030 Sales CAGR Of +5-6% CC

Reuters
·
Nov 20, 2025

BRIEF-Avidity Biosciences Announces U.S. Managed Access Program (Map) For Investigational Therapy Del-Zota In Dmd44

Reuters
·
Nov 19, 2025

Avidity Biosciences Inc - Plans Bla Submission for Del-Zota in 2026

THOMSON REUTERS
·
Nov 19, 2025

BAIJIN LIFE SCI (01466) Subsidiary Plans to Invest in YouHuan Bio to Build a Globally Leading circRNA Technology R&D Platform

Stock News
·
Nov 19, 2025

Baijin Life Science Enters Strategic Partnership to Advance RNA Technology

TIPRANKS
·
Nov 19, 2025

Mirxes Partners with Walvax to Advance RNA-Centric Precision Medicine

TIPRANKS
·
Nov 18, 2025

MIRXES-B (02629) Signs MOU with Watson to Establish RNA-Centric Preventive and Precision Medicine Platform

Stock News
·
Nov 18, 2025

Circio Holding ASA to Present Latest circVec RNA Platform Results in Upcoming Webcast

TIPRANKS
·
Nov 17, 2025

Hold Rating on Avidity Biosciences Amid Novartis Acquisition and Strategic Developments

TIPRANKS
·
Nov 12, 2025

Chardan Capital Reaffirms Their Hold Rating on Avidity Biosciences (RNA)

TIPRANKS
·
Nov 12, 2025